Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Senzime AB ( (SE:SEZI) ) just unveiled an update.
Senzime AB, a Swedish medical device company, develops and markets precision-based perioperative monitoring systems, most notably the TetraGraph platform for neuromuscular transmission monitoring in the operating room. Its technology is deployed in thousands of surgical suites globally, supporting safer anesthesia management and reinforcing Senzime’s positioning as a specialist in patient safety-focused monitoring solutions.
The company has announced that its first-quarter 2026 report will be released on April 22, followed by a webcast presentation by CEO Philip Siberg and a live Q&A session hosted via Redeye’s platform later that morning. The planned presentations underscore Senzime’s efforts to maintain active dialogue with investors, analysts, and media, offering stakeholders timely insight into its financial performance and strategic progress in a rapidly evolving healthcare technology market.
More about Senzime AB
Senzime AB is a Sweden-based medical device company focused on precision monitoring systems that enhance perioperative patient safety. Founded in 1999 and headquartered in Uppsala, it markets the TetraGraph system for neuromuscular transmission monitoring during surgery, and its products are used in operating rooms worldwide. The company is listed on Nasdaq Stockholm Main Market under the ticker SEZI and cross-traded on the US OTCQX Market as SNZZF, supported by long-term investors and positioned at the forefront of a healthcare market shaped by new clinical guidelines and technologies.
Senzime’s flagship TetraGraph solution is promoted as a best-in-class tool to ensure accurate dosing of paralytic drugs and provide deeper clinical insight from anesthesia through recovery. By focusing on improving outcomes and reducing costs, Senzime targets hospitals and surgical centers seeking to modernize operating room monitoring and align with stricter patient safety standards.
Average Trading Volume: 222,691
Technical Sentiment Signal: Sell
Current Market Cap: SEK811.2M
For an in-depth examination of SEZI stock, go to TipRanks’ Overview page.